Featured Image
Why is it important?
It is demonstrated that SSTR2 induction in mouse pheochromocytoma models has some therapeutic benefit that occurs via yet unknown mechanisms, and first insights into genetic responses of PCCs/PGLs, potentially useful for developing additional strategies to prevent tumor recurrence.
Read the Original
This page is a summary of: Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models, Theranostics, January 2023, Ivyspring International Publisher,
DOI: 10.7150/thno.77918.
You can read the full text:
Contributors
The following have contributed to this page
